Literature DB >> 19506573

X chromosome reactivation perturbs intracellular self/not-self discrimination.

Donald R Forsdyke1.   

Abstract

New reports indicate a chromosomal rather than hormonal basis for the susceptibility of females to autoimmune disease. It is held that if females reactivate an inactivated X chromosome, there will be overexpression of certain X-located genes affecting immune function. Hence, normal mechanisms of self/not-self discrimination might be impaired resulting in immune reaction to self antigens. However, the data are also consistent with the long-held view that the demands of intracellular self/not-self discrimination have driven the evolution of X-chromosome dosage compensation. It was proposed that, whether cells are in male or female bodies, concentrations of proteins are fine-tuned up to their aggregation thresholds. A disruption of this equilibrium, by agents originating either externally (for example, virus) or internally (for example, reactivated X chromosome), generates homoaggregates that trigger responses against the respective not-self or self antigens. Thus, female susceptibility to autoimmune disease may not be because certain immune system genes happen to be X-located, but because self/not-self discrimination was the raison d'être for X-chromosome dosage compensation in the first place.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506573     DOI: 10.1038/icb.2009.39

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  7 in total

Review 1.  Lymphocyte repertoire selection and intracellular self/non-self-discrimination: historical overview.

Authors:  Donald R Forsdyke
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

2.  Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome.

Authors:  Rohan Sharma; Valerie M Harris; Joshua Cavett; Biji T Kurien; Ke Liu; Kristi A Koelsch; Anum Fayaaz; Kaustubh S Chaudhari; Lida Radfar; David Lewis; Donald U Stone; C Erick Kaufman; Shibo Li; Barbara Segal; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Jennifer A Kelly; Bernardo Pons-Estel; Roland Jonsson; Xianglan Lu; Jacques-Eric Gottenberg; Juan-Manuel Anaya; Deborah S Cunninghame-Graham; Andrew J W Huang; Michael T Brennan; Pamela Hughes; Ilias Alevizos; Corinne Miceli-Richard; Edward C Keystone; Vivian P Bykerk; Gideon Hirschfield; Gunnel Nordmark; Sara Magnusson Bucher; Per Eriksson; Roald Omdal; Nelson L Rhodus; Maureen Rischmueller; Michael Rohrer; Marie Wahren-Herlenius; Torsten Witte; Marta Alarcón-Riquelme; Xavier Mariette; Christopher J Lessard; John B Harley; Wan-Fai Ng; Astrid Rasmussen; Kathy L Sivils; R Hal Scofield
Journal:  Arthritis Rheumatol       Date:  2017-10-12       Impact factor: 10.995

3.  Sex chromosome aneuploidies among men with systemic lupus erythematosus.

Authors:  Skyler P Dillon; Biji T Kurien; Shibo Li; Gail R Bruner; Kenneth M Kaufman; John B Harley; Patrick M Gaffney; Daniel J Wallace; Michael H Weisman; R Hal Scofield
Journal:  J Autoimmun       Date:  2011-12-06       Impact factor: 7.094

Review 4.  The X chromosome in immune functions: when a chromosome makes the difference.

Authors:  Claude Libert; Lien Dejager; Iris Pinheiro
Journal:  Nat Rev Immunol       Date:  2010-08       Impact factor: 53.106

5.  Inherent X-Linked Genetic Variability and Cellular Mosaicism Unique to Females Contribute to Sex-Related Differences in the Innate Immune Response.

Authors:  Zoltan Spolarics; Geber Peña; Yong Qin; Robert J Donnelly; David H Livingston
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

6.  In gender-based outcomes, sex hormones may be important but it is in the genes*.

Authors:  Zoltán Spolarics
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

Review 7.  What can pestiviral endonucleases teach us about innate immunotolerance?

Authors:  Carmela Lussi; Matthias Schweizer
Journal:  Cytokine Growth Factor Rev       Date:  2016-03-17       Impact factor: 7.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.